AR051727A1 - Formulacion oral de liberacion inmediata de una sustancia activa poco soluble en agua - Google Patents

Formulacion oral de liberacion inmediata de una sustancia activa poco soluble en agua

Info

Publication number
AR051727A1
AR051727A1 ARP050105358A ARP050105358A AR051727A1 AR 051727 A1 AR051727 A1 AR 051727A1 AR P050105358 A ARP050105358 A AR P050105358A AR P050105358 A ARP050105358 A AR P050105358A AR 051727 A1 AR051727 A1 AR 051727A1
Authority
AR
Argentina
Prior art keywords
active substance
immediate release
release formulation
water
oral immediate
Prior art date
Application number
ARP050105358A
Other languages
English (en)
Inventor
Rohit Kumar
Winter Marius L De
Rajesh Jain
Sukhjeet Singh
Original Assignee
Solvay Pharm Bv
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv, Panacea Biotec Ltd filed Critical Solvay Pharm Bv
Publication of AR051727A1 publication Critical patent/AR051727A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere a un formulacion oral de liberacion inmediata de derivados del ácido benzazepin-1-acético que comprende: a) dicha sustancia activa en una cantidad de hasta 65% del peso total de la formulacion; b) al menos 10% p/p de un compuesto alcalino o una mezcla de compuestos alcalinos; c) entre 0,1 y 10% p/p de uno o más agentes tensoactivos; y d) opcionalmente materiales auxiliares en una cantidad comprendida entre 1% y 45% del peso total de la formulacion.
ARP050105358A 2004-12-23 2005-12-20 Formulacion oral de liberacion inmediata de una sustancia activa poco soluble en agua AR051727A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04106933 2004-12-23

Publications (1)

Publication Number Publication Date
AR051727A1 true AR051727A1 (es) 2007-01-31

Family

ID=34930144

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105358A AR051727A1 (es) 2004-12-23 2005-12-20 Formulacion oral de liberacion inmediata de una sustancia activa poco soluble en agua

Country Status (16)

Country Link
EP (1) EP1848439B1 (es)
JP (1) JP2008525368A (es)
CN (1) CN101087612A (es)
AR (1) AR051727A1 (es)
AT (1) ATE460167T1 (es)
AU (1) AU2005318199B2 (es)
BR (1) BRPI0519248A2 (es)
CA (1) CA2590848A1 (es)
ES (1) ES2342548T3 (es)
MX (1) MX2007007609A (es)
PL (1) PL1848439T3 (es)
RU (1) RU2382649C2 (es)
SA (1) SA05260422B1 (es)
TW (1) TW200633713A (es)
UA (1) UA90700C2 (es)
WO (1) WO2006067150A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
ATE509620T1 (de) * 2006-06-16 2011-06-15 Abbott Healthcare Products Bv Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz
AU2007263016A1 (en) * 2006-06-22 2007-12-27 Panacea Biotec Ltd. Oral pharmaceutical composition of a poorly water-soluble active substance
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances

Also Published As

Publication number Publication date
SA05260422B1 (ar) 2009-09-08
ATE460167T1 (de) 2010-03-15
RU2382649C2 (ru) 2010-02-27
WO2006067150A1 (en) 2006-06-29
UA90700C2 (ru) 2010-05-25
MX2007007609A (es) 2007-08-03
BRPI0519248A2 (pt) 2009-01-06
RU2007127847A (ru) 2009-01-27
AU2005318199B2 (en) 2011-04-28
EP1848439B1 (en) 2010-03-10
EP1848439A1 (en) 2007-10-31
ES2342548T3 (es) 2010-07-08
AU2005318199A1 (en) 2006-06-29
JP2008525368A (ja) 2008-07-17
CN101087612A (zh) 2007-12-12
CA2590848A1 (en) 2006-06-29
PL1848439T3 (pl) 2010-11-30
TW200633713A (en) 2006-10-01

Similar Documents

Publication Publication Date Title
PE20070583A1 (es) Formulacion que comprende un inhibidor de dipeptidil-peptidasa iv y metformina
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
PE20080123A1 (es) Composiciones farmaceuticas que contienen vx-950 en el tratamiento de hepatitis c
AR059113A1 (es) Composicion para administracion topica
ECSP055568A (es) Composición de comprimido de liberación sostenida de pramipexol
PE20070458A1 (es) Composicion farmaceutica que comprende 2-[[6-(3r)-3-amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-benzonitrilo como inhibidor de dipeptidil peptidasa
ATE375142T1 (de) Medizinische aerosolformulierungen
BR0015567A (pt) Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos
PE20061046A1 (es) Composicion farmaceutica que comprende telmisartan y amlodipino
PE20010053A1 (es) Formulacion de amoxicilina y clavulanato de potasio
IL179718A0 (en) Pharmaceutical composition containing irbesartan
SV2008002612A (es) Forma de dosificacion de liberacion retardada oral altamente biodisponibles de succionado de o-desmetilvanlafaxina ref. am101721salvo
CR9803A (es) Agentes de esparcido formadores de pelicula
RU2011154329A (ru) Композиции на основе бориновой кислоты
BR0307278A (pt) Formulação oral de liberação imediata, e, método para preparar uma formulação
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
AR051727A1 (es) Formulacion oral de liberacion inmediata de una sustancia activa poco soluble en agua
BR0317924A (pt) Formas de dosagem não aquosas de composto de prostaglandina e
PA8586301A1 (es) Formulaciones de liberacion prolongada en forma de suspension
ATE528009T1 (de) Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten
PE20070809A1 (es) Composicion veterinaria que comprende closantel
AR039935A1 (es) Formulacion farmaceutica de liberacion inmediata
BRPI0418070A (pt) composição para cuidados pessoais, uso de uma uréia substituìda e método para reduzir a degradação da cor de uma composição para cuidados pessoais
NO20044723L (no) Injiserbare veterinaermedisinske sammensetninger for sma dyr
PE20060001A1 (es) COMPUESTOS DE ß-CETOAMIDA COMO ANTAGONISTAS DE MCH

Legal Events

Date Code Title Description
FA Abandonment or withdrawal